Rating: Buy
Bristol-Myers Squibb Financial Health
Profitability:3.17/10
❌ Bristol-Myers Squibb has worst Profitability than 75% of the companies on the Drug Manufacturers industry
Net Margin: 3.08%
❌ Bristol-Myers Squibb has worst Net Margin than 66.67% of the companies on the Drug Manufacturers industry
ROE (Return on Equity): 0.71%
❌ Bristol-Myers Squibb has worst ROE (Return on Equity) than 66.67% of the companies on the Drug Manufacturers industry
ROA (Return on Assets): 0.26%
❌ Bristol-Myers Squibb has worst ROA (Return on Assets) than 75% of the companies on the Drug Manufacturers industry
Operating Efficiency:9.66/10
✅ Bristol-Myers Squibb has better Operating Efficiency than 66.67% of the companies on the Drug Manufacturers industry
Operating Margin: 48.22%
✅ Bristol-Myers Squibb has better Operating Margin than 66.67% of the companies on the Drug Manufacturers industry
Liquidity:6.59/10
✅ Bristol-Myers Squibb has better Liquidity than 75% of the companies on the Drug Manufacturers industry
Quick Ratio: 1.51
✅ Bristol-Myers Squibb has better Quick Ratio than 75% of the companies on the Drug Manufacturers industry
Operating Cash Flow Ratio: 0.55
❌ Bristol-Myers Squibb has worst Operating Cash Flow Ratio than 50% of the companies on the Drug Manufacturers industry
Solvency:4.43/10
❌ Bristol-Myers Squibb has worst Solvency than 75% of the companies on the Drug Manufacturers industry
Debt to Equity Ratio: 0.93
❌ Bristol-Myers Squibb has worst Debt to Equity Ratio than 66.67% of the companies on the Drug Manufacturers industry
Interest Coverage Ratio: 0.55
❌ Bristol-Myers Squibb has worst Interest Coverage Ratio than 50% of the companies on the Drug Manufacturers industry